A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres

被引:56
作者
D'Souza S.S. [1 ]
Faraj J.A. [1 ]
DeLuca P.P. [1 ,2 ]
机构
[1] University of Kentucky, College of Pharmacy, Lexington
[2] Faculty of Pharmaceuticals Sciences, University of Kentucky, College of Pharmacy, Lexington
关键词
Accelerated in vitro release; Biodegradable microspheres; Modified Weibull equation; Sigmoidal triphasic release;
D O I
10.1208/pt060470
中图分类号
学科分类号
摘要
The purpose of this study was to determine the feasibility of applying accelerated in vitro release testing to correlate or predict long-term in vitro release of leuprolide poly(lactide-co-glycolide) microspheres. Peptide release was studied using a dialysis technique at 37°C and at elevated temperatures (50°C-60°C) in 0.1M phosphate buffered saline (PBS) pH 7.4 and 0.1M acetate buffer pH 4.0. The data were analyzed using a modification of the Weibull equation. Peptide release was temperature dependent and complete within 30 days at 37°C and 3 to 5 days at the elevated temperatures. In vitro release profiles at the elevated temperatures correlated well with release at 37°C. The shapes of the release profiles at all temperatures were similar. Using the modified Weibull equation, an increase in temperature was characterized by an increase in the model parameter, α, a scaling factor for the apparent rate constant. Complete release at 37°C was shortened from ∼30 days to 5 days at 50°C, 3.5 days at 55°C, 2.25 days at 60°C in PBS pH 7.4, and 3 days at 50°C in acetate buffer pH 4.0. Values for the model parameter β indicated that the shape of the release profiles at 55°C in PBS pH 7.4 (2.740) and 50°C in 0.1M acetate buffer pH 4.0 (2.711) were similar to that at 37°C (2.677). The Ea for hydration and erosion were determined to be 42.3 and 19.4 kcal/mol, respectively. Polymer degradation was also temperature dependent and had an Ea of 31.6 kcal/mol. Short-term in vitro release studies offer the possibility of correlation with long-term release, thereby reducing the time and expense associated with long-term studies. Accelerated release methodology could be useful in the prediction of long-term release from extended release microsphere dosage forms arid may serve as a quality control tool for the release of clinical or commercial batches. Copyright ©2003. All Rights Reserved.
引用
收藏
页数:14
相关论文
共 24 条
[1]  
Ramstack M., Grandolfi G., Mannaert E., D'Hoore P., Lasser R.A., Long-acting risperidone: Prolonged-release injectable delivery of risperidone using Medisorb microsphere technology, Schizophrenia Research, 60, SUPPL., (2003)
[2]  
Kostanski J.W., Thanoo B.C., DeLuca P.P., Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres, Pharm. Dev. Technol., 5, pp. 585-596, (2000)
[3]  
D'Souza S.S., Selmin F., Murty S.B., Qiu W., Thanoo B.C., DeLuca P.P., Assessment of fertility in male rats after extended chemical castration with a GnRH antagonist, AAPS PharmSci., 6, (2004)
[4]  
Woo B.H., Na K.-H., Dani B.A., Jiang G., Thanoo B.C., DeLuca P.P., In vitro characterization and in vivo testosterone suppression of 6-month release poly(D,L-lactide) leuprolide microspheres, Pharm. Res., 19, pp. 546-550, (2002)
[5]  
Okada H., Doken Y., Ogawa Y., Toguchi H., Preparation of three-month injectable microspheres of leuprorelin acetate using biodegradable polymers, Pharm. Res., 11, pp. 1143-1147, (1994)
[6]  
Kane J.M., Eerdekens M., Lindenmayer J.-P., Keith S.J., Lesem M., Karcher K., Long-acting injectable Risperidone: Efficacy and safety of the first long-acting atypical antipsychotic, Am. J. Psychiatry, 160, pp. 1125-1132, (2003)
[7]  
Siewert M., Dressman J., Brown C.K., Shah V.P., FIP/AAPS guidelines to dissolution/in vitro release testing of novel /special dosage forms, AAPS PharmSciTech., 4, (2003)
[8]  
Buchholz B., Accelerated degradation test on resorbable polymers, Degradation Phenomena of Polymeric Biomaterials, pp. 67-76, (1992)
[9]  
Makino K., Arakawa M., Kondo T., Preparation and in vitro degradation properties of polylactide microcapsules, Chem. Pharm. Bull. (Tokyo), 33, pp. 1195-1201, (1985)
[10]  
Bergsma J.E., Rozema F.R., Bos R.R.M., Boering G., Joziasse C.A.P., Pennings A.J., In vitro predegradation at elevated temperatures of poly(lactide), J. Mater. Sci. Mater. Med., 6, pp. 642-646, (1995)